Clinical Trials Logo

Citation(s)

Phase II Stereotactic Body Radiotherapy (SBRT) and Stereotactic Hypofractionated Radiotherapy (SHRT) for Oligometastatic Prostate Cancer

Details for clinical trial NCT01859221